Læknablaðið - 15.05.2006, Side 16

FRÆÐIGREINAR /CARCINOMA ANI
of invasion, location and size of cancer of the anus
dictatepoerative treatment. Cancer 1983; 51: 729-34.
8. Schneider TC, Schulte WJ. Management of carcinoma of the
anal canal. Surgery 1981; 20: 729-34.
9. Boman BM, Moertel CG, O'Connell MJ. Scott M, Weiland
LH, Beart RW, et al. Carcinoma of the anal canal. A clinical
and pathologic study of 188 cases. Cancer 1984; 54:114-25.
10. Dougherty BG, Evans HL. Carcinoma of the anal canal. A
study of 79 cases. Am J Clin Pathol 1985; 83:159-64.
11. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg
1976; 184: 422-8.
12. Singh R, Nime F, Mittelman A. Malignant epithelial tumors of
the anal canal. Cancer 1981; 48: 411-5.
13. Klotz RG, Pamukgoglu T, Souilliard DH. Transitional
cloacogenic carcinoma of the anal canal: clinicopathologic
study of three hundred seventy-three cases. Cancer 1967; 20:
1727-45.
14. Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ,
Picus J, et al. Radiation therapy for epidermoid carcinoma of
the anal canal, clinical and treatment factors associated with
outcome. Radiother oncol 2001; 61:15-22.
15. Greene FL, Page DL, Irvin DM, Fritz AG, Balch CM, Haller
DG, et al. Anal Canal. In: AJCC cancer staging manual. 2002.
6th. ed. Chicago: Springer 2002:125-30.
16. Goldman S, Auer G, Erhardt K, Seligson U. Prognostic
significance of clinical stage, histologic grade and nuclear
DNA content in squamous-cell carcinoma of the anus. Dis
Colon Rectum 1987; 30: 444-8.
17. Maggard MA, Beanes SR, Ko CY. Anal canal cancer. A
population-based reappraisal. Dis Colon Rectum 2003; 46:
1517-24.
18. Hung A, Crane C, Declos M, Ballo M, Ajani J, Lin E, et
al. Cisplatin-based combined modality therapy for anal
carcinoma. Cancer 2003; 97:1195-202.
19. Frisch M, Glimelius B, Wohlfahrt J, Adami HO,Melbye
M. Tobacco smoking as a risk factor in anal carcinoma: an
antiestrogenic mechanism? J Natl Cancer Inst 1999; 91: 708-
15.
20. Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin
LH, Lasota J. Gastrointestinal stromal tumors, intramural
leiomyomas, and leiomyosarcomas in the rectum and anus.
A clinicopathologic, immunohistochemical, and molecular
genetic study of 144 cases. Am J Surg Pathol 2001; 25: 1121-
33.
21. Viðarsdóttir H, Möller PH, Tryggvason G, Kjartanson S,
Jónasson JG. Strómaæxli í meltingarvegi - sjúkratilfelli.
Læknablaðið 2005; 2:177-9.
22. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti
MC. Effectiveness of surgical salvage therapy for patients with
locally uncontrolled anal carcinoma after sphincter-conserving
treatment. Cancer 1999; 86:405-9.
23. Touboul E Schlienger M, Buffat L, Lefkopoulos D, Péne F,
Parc R. Epidermoid carcinoma of the anal canal. Results of
curative intent radiation therapy in a series of 270 patients.
Cancer 1994; 73:1569-79.
24. Gerard JP, Ayzac L, Hun D, Rometang P, Coquard R, Ardiet
JM, et al. Treatment of anal canal carcinoma with high dose
radiation therapy and concomitant fluoruracil-cisplatinum.
Long-term results in 95 patients. Radiother oncol 1998; 46:
249-56.
372 Læknablaðið 2006/92